3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Fallopian Tube Neoplasms
4
Ovarian Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sarcoma, Alveolar Soft Part
1
Prostatic Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Leiomyosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Colorectal Neoplasms
1
Carcinosarcoma
1
Carcinoma, Endometrioid
1
Interventions
Magnetic Resonance Spectroscopy
5
trametinib
4
Vemurafenib
4
selpercatinib
3
dabrafenib
3
Specimen Handling
3
entrectinib
2
cobimetinib
2
cabozantinib
2
X-Rays
2
Iodine-131
2
Interviews as Topic
2
tremelimumab
1
tovorafenib
1
spartalizumab
1
pembrolizumab
1
omipalisib
1
lenvatinib
1
gallium Ga 68 dotatate
1
durvalumab
1
copanlisib
1
Whole Body Imaging
1
Transurethral Resection of Prostate
1
Thyrotropin Alfa
1
Surveys and Questionnaires
1
Sodium Iodide
1
Robotic Surgical Procedures
1
Postoperative Period
1
Phantoms, Imaging
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Cancer, Papillary
×
cediranib
×
1 year
×
Clear all
No trials found.